Form 4 for ABT Abbott Laboratories
Accepted 2025-01-30 00:00:00 ET · period of report 2025-01-28 · accession 0001415889-25-002423 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-01-30 | 2025-01-28 | ABT | Morrone Louis H. | EVP | S - Sale | $127.39 | -2,644 | 0 | -100% | -$336.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2025-01-28 | S | D | 2,644 | $127.39 | 0 | I Profit Sharing Trust | — | — | (F1) Includes shares acquired pursuant to a dividend reinvestment feature. (F2) Balance in the Abbott Laboratories Stock Retirement Trust as of January 29, 2025. |